MCID: CRR007
MIFTS: 44

Cirrhosis, Cryptogenic malady

Categories: Genetic diseases, Liver diseases, Rare diseases

Aliases & Classifications for Cirrhosis, Cryptogenic

About this section

Aliases & Descriptions for Cirrhosis, Cryptogenic:

Name: Cirrhosis, Cryptogenic 51 25 12 67
Cryptogenic Cirrhosis 25 69 26
Cirrhosis, Noncryptogenic 51 26
Cirrhosis 69 67
Cirrhosis, Familial Cirrhosis, Familial, with Pulmonary Hypertension, Included 51
 
Non-Wilsonian Hepatic Copper Toxicosis of Infancy and Childhood 53
Cirrhosis, Noncryptogenic, Susceptibility to 12
Idiopathic Copper-Associated Cirrhosis 53
Liver Cirrhosis 67
Cirrh 69

Characteristics:

Orphanet epidemiological data:

53
non-wilsonian hepatic copper toxicosis of infancy and childhood:
Age of onset: Childhood; Age of death: adolescent,late childhood

Classifications:

Orphanet: 53 
Rare hepatic diseases


External Ids:

OMIM51 215600
Orphanet53 ORPHA209919
ICD10 via Orphanet30 K74.6

Summaries for Cirrhosis, Cryptogenic

About this section
UniProtKB/Swiss-Prot:69 Cirrhosis: A liver disease characterized by severe panlobular liver-cell swelling with Mallory body formation, prominent pericellular fibrosis, and marked deposits of copper. Clinical features include abdomen swelling, jaundice and pulmonary hypertension.

MalaCards based summary: Cirrhosis, Cryptogenic, also known as cryptogenic cirrhosis, is related to primary biliary cirrhosis and liver cirrhosis, and has symptoms including jaundice, lethargy and micronodular cirrhosis. An important gene associated with Cirrhosis, Cryptogenic is KRT8 (Keratin 8), and among its related pathways are Cytoskeletal Signaling and EGFR1 Signaling Pathway. The drugs milk thistle extract and bumetanide have been mentioned in the context of this disorder. Affiliated tissues include liver and lung.

Genetics Home Reference:25 Cryptogenic cirrhosis is a condition that impairs liver function. People with this condition develop irreversible liver disease caused by scarring of the liver (cirrhosis), typically in mid- to late adulthood.

Description from OMIM:51 215600

Related Diseases for Cirrhosis, Cryptogenic

About this section

Diseases related to Cirrhosis, Cryptogenic via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 523)
idRelated DiseaseScoreTop Affiliating Genes
1primary biliary cirrhosis12.4
2liver cirrhosis12.4
3cirrhosis, north american indian childhood type12.3
4alcoholic liver cirrhosis12.2
5hypermanganesemia with dystonia, polycythemia, and cirrhosis12.2
6biliary cirrhosis, primary, 112.0
7biliary cirrhosis, primary, 312.0
8biliary cirrhosis, primary, 212.0
9biliary cirrhosis, primary, 412.0
10biliary cirrhosis, primary, 512.0
11reynolds syndrome11.8
12berry aneurysm, cirrhosis, pulmonary emphysema, and cerebral calcification11.8
13hemochromatosis11.7
14mitochondrial dna depletion syndrome 4a11.5
15primary biliary cholangitis11.4
16hepatocellular carcinoma11.4
17glycogen storage disease iv11.3
18emphysema due to aat deficiency11.3
19hepatitis11.3
20hepatitis c11.3
21hepatitis b11.2
22hepatitis c virus11.1
23wilson disease11.1
24hypobetalipoproteinemia11.0
25hepatorenal syndrome11.0
26liver disease11.0
27alcoholic hepatitis11.0
28nodular regenerative hyperplasia10.9
29cystic fibrosis10.9
30alcohol abuse10.9
31budd-chiari syndrome10.9
32tyrosinemia, type i10.9
33cholesterol ester storage disease10.9
34secondary sclerosing cholangitis10.9
35cholangitis, primary sclerosing10.9
36wolman disease10.8
37cholestasis, progressive familial intrahepatic 110.8
38hemochromatosis, type 2a10.7
39cholestasis-lymphedema syndrome10.7
40glycogen storage disease ixc10.7
41fatty liver disease, nonalcoholic 110.7
42scalp-ear-nipple syndrome10.7
43glycogen storage disease iiia10.6
44cholestasis, progressive familial intrahepatic 210.6
45hemochromatosis, type 410.6
46vasculopathy, retinal, with cerebral leukodystrophy10.6
47cholestasis, progressive familial intrahepatic 310.6
48hemochromatosis, type 310.6
49bile acid synthesis defect, congenital, 310.6
50cholestasis, progressive familial intrahepatic 410.6

Graphical network of the top 20 diseases related to Cirrhosis, Cryptogenic:



Diseases related to cirrhosis, cryptogenic

Symptoms for Cirrhosis, Cryptogenic

About this section

Symptoms by clinical synopsis from OMIM:

215600

Clinical features from OMIM:

215600

Human phenotypes related to Cirrhosis, Cryptogenic:

 63 (show all 7)
id Description HPO Frequency HPO Source Accession
1 jaundice63 HP:0000952
2 lethargy63 HP:0001254
3 micronodular cirrhosis63 HP:0001413
4 fever63 HP:0001945
5 esophageal varix63 HP:0002040
6 pulmonary hypertension63 HP:0002092
7 abdominal distention63 HP:0003270

UMLS symptoms related to Cirrhosis, Cryptogenic:


abdominal pain, constipation, diarrhea, dyspepsia, heartburn, hepatomegaly, hepatosplenomegaly, nausea and vomiting, gastrointestinal gas

Drugs & Therapeutics for Cirrhosis, Cryptogenic

About this section

Drugs for Cirrhosis, Cryptogenic (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 32)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1Liver ExtractsPhase 2, Phase 33868
2Hypoglycemic AgentsPhase 25733
3IncretinsPhase 21537
4Sitagliptin PhosphatePhase 2416
5Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 212767
6
protease inhibitorsPhase 25320
Synonyms:
 
protease inhibitors
7HormonesPhase 213979
8Dipeptidyl-Peptidase IV InhibitorsPhase 2846
9HIV Protease InhibitorsPhase 25319
10Hormone AntagonistsPhase 212778
11
Pentoxifyllineapproved, investigational996493-05-64740
Synonyms:
1,2,3,6-Tetrahydro-3,7-dimethyl-1-(5-oxohexyl)-2,6-purindion
1-(5-Oxohexyl)-3,7-dimethylxanthine
1-(5-Oxohexyl)theobromine
2a3c
3,7-Dihydro-3,7-dimethyl-1-(5-oxohexyl)-1H-purine-2,6-dione
3,7-Dimethyl-1-(5-oxo-hexyl)-3,7-dihydro-purine-2,6-dione
3,7-Dimethyl-1-(5-oxohexyl) xantine
3,7-Dimethyl-1-(5-oxohexyl)-1H,3H-purin-2,6-dione
3,7-Dimethyl-1-(5-oxohexyl)-3,7-dihydro-1H-purine-2,6-dione
3,7-Dimethyl-1-(5-oxohexyl)xanthine
3,7-Dimethyl-1-(5-oxohexyl)xantine
3,7-dimethyl-1-(5-oxohexyl)purine-2,6-dione
5-26-14-00081 (Beilstein Handbook Reference)
6493-05-6
AB00052363
AC1L1IUN
AKOS000541484
Agapurin
Agapurin Retard
Azupentat
BAS 00897429
BB_SC-2111
BIDD:GT0174
BL 191
BL-191
BL191
BPBio1_000167
BRD-K57569181-001-05-1
BRN 0558929
BSPBio_000151
BSPBio_003439
C07424
C13H18N4O3
CAS-1677687
CCRIS 6832
CHEMBL628
CID4740
CPD000035998
D00501
D010431
DB00806
Dimethyloxohexylxanthine
DivK1c_000729
Durapental
EHT 0201
EHT-0201
EHT-201
EHT0201
EINECS 229-374-5
EU-0100936
HMS1568H13
HMS1922E16
HMS2051N06
HMS2090H13
HMS2093G21
HMS502E11
Hemovas
I06-1592
IDI1_000729
IN1161
Ikomio
KBio1_000729
KBio2_001924
KBio2_004492
KBio2_007060
KBio3_002942
KBioGR_000893
KBioSS_001924
LS-149385
 
Lopac-P-1784
Lopac0_000936
MLS000079026
MLS000758298
MLS001201764
MolPort-001-823-263
NCGC00015801-01
NCGC00015801-02
NCGC00015801-04
NCGC00015801-10
NCGC00067069-02
NCGC00067069-03
NCGC00067069-04
NCGC00067069-05
NCGC00178062-01
NCGC00178062-02
NINDS_000729
NSC 637086
NSC637086
Oxpentifylline
P 1784
PDSP1_001015
PDSP2_000999
PENTOXYPHYLINE
PNX
Pentoxifilina
Pentoxifilina [INN-Spanish]
Pentoxifyllin
Pentoxifylline
Pentoxifylline (JAN/USP/INN)
Pentoxifylline [USAN:INN:JAN]
Pentoxifyllinum
Pentoxifyllinum [INN-Latin]
Pentoxil
Pentoxil (TN)
Pentoxiphyllin
Pentoxiphylline
Pentoxiphyllium
Pentoxyfylline
Pentoxyphyllin
Pentoxyphylline
Prestwick0_000196
Prestwick1_000196
Prestwick2_000196
Prestwick3_000196
Prestwick_608
Px
Ralofect
Rentylin
SAM001247011
SMR000035998
SPBio_001221
SPBio_002072
SPECTRUM1503611
SR-01000075641-4
STK177321
Spectrum2_001181
Spectrum3_001820
Spectrum4_000227
Spectrum5_001161
Spectrum_001444
Torental
Trental
Trental (TN)
UNII-SD6QCT3TSU
Vasofirin
Vazofirin
ZINC01530776
cis-9-Octadecenoyl coenzyme A
pentoxifylline
12
Metforminapproved1746657-24-914219, 4091
Synonyms:
1,1-Dimethyl biguanide
1,1-Dimethylbiguanide
3-(diaminomethylidene)-1,1-dimethylguanidine
657-24-9
AC1L1HE4
AKOS000121065
Apo-Metformin
BIDD:GT0697
BPBio1_000009
BRD-K79602928-003-04-1
BSPBio_000007
BSPBio_002314
C07151
C4H11N5
CAS-1115-70-4
CCRIS 9321
CHEBI:6801
CHEMBL1431
CID4091
D04966
DB00331
DMGG
Diabetosan
Diabex
Dimethylbiguanid
Dimethylbiguanide
Dimethylbiguanidine
Dimethyldiguanide
Dimethylguanylguanidine
EINECS 211-517-8
Fluamine
Flumamine
Fortamet
Gen-Metformin
Glifage
Gliguanid
Glucophage
Glucophage XR
Glumetza
Glycon
HMS2089D19
HSCI1_000295
Haurymelin
Haurymellin
Islotin
KBio2_002310
KBio2_004878
KBio2_007446
KBio3_002790
KBioGR_002310
 
KBioSS_002312
LA-6023
LS-43899
Melbin
Metformin
Metformin (USAN/INN)
Metformin HCL
Metformin [USAN:INN:BAN]
Metformina
Metformina [DCIT]
Metformina [Spanish]
Metformine
Metformine [INN-French]
Metformine pamoate
Metforminum
Metforminum [INN-Latin]
Metiguanide
MolPort-002-929-560
MolPort-004-288-389
MolPort-005-767-418
Mylan-Metformin
N,N-Dimethylbiguanide
N,N-Dimethyldiguanide
N,N-Dimethylimidodicarbonimidic diamide
N,N-dimethylimidodicarbonimidic diamide
N1,N1-Dimethylbiguanide
NCGC00016564-01
NCGC00016564-02
NCGC00016564-03
NNDG
Novo-Metformin
Nu-Metformin
PMS-Metformin
Prestwick0_000004
Prestwick1_000004
Prestwick2_000004
Prestwick3_000004
Ran-Metformin
Ratio-Metformin
Riomet
S2483_Selleck
SPBio_001928
STK011633
Sandoz Metformin
Siofor
T5895664
Teva-Metformin
UNII-9100L32L2N
ZINC12859773
cMAP_000016
metformin
metformin hydrochloride
13
Zincapproved22317440-66-632051, 23994
Synonyms:
30Zn
Cinc
Zinc
Zinc ion
 
Zincum
Zink
Zn
Zn(ii)
Zn2+
14
Heparinapproved, investigational8129005-49-6772, 46507594
Synonyms:
101921-26-0
102-94-3
102785-31-9
104521-37-1
11078-24-3
11129-39-8
12656-11-0
2-o-sulfohexopyranuronosyl-(1->4)-2-deoxy-3-o-sulfo-2-(sulfoamino)hexopyranosyl-(1->4)-2-o-sulfohexopyranuronosyl-(1->4)-2-acetamido-2-deoxy-6-o-sulfohexopyranose
37324-73-5
6-[6-[6-[5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-2-carboxy-4-hydroxy-5-sulfooxyoxan-3-yl]oxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxyoxan-3-yl]oxy-3,4-dihydroxy-5-sulfooxyoxane-2-carboxylic acid
9041-08-1
9045-22-1
9075-96-1
913079-23-9
91449-79-5
AC1L19ZN
AC1L1ROY
ALFA 87-120
ALFA 87-163
ALFA 87-198
ALFA 87-81
ALFA 88-247
AR-1E4539
Allocinnamic acid
Ardeparin
Ardeparin sodium
Arteven
Bemiparin
Bemiparin sodium
CID772
CID8784
CY 216
Calciparine
Certoparin
Clexane
Clivarin
Clivarine
Cy 222
D006495
D017984
DB00407
DB01225
Dalteparin
Dalteparin sodium
Depo-Heparin
EINECS 232-681-7
EMT 966
EMT 967
EMT-966
EMT-967
EMT966
EMT967
Enoxaparin
Enoxaparin sodium
Enoxaparine
Eparina
Eparina [DCIT]
FR 860
Fluxum
Fragmin A
Fragmin B
Fragmin IV
Fraxiparin
H 2149
HSDB 3094
Hed-heparin
Hep Flush Kit in plastic container
Hep-Lock
Hep-Lock U/P
Hep-lock
Heparin
Heparin CY 216
Heparin Lock Flush
Heparin Lock Flush in plastic container
Heparin Lock Flush preservative free
Heparin Lock Flush preservative free in plastic container
Heparin Sodium
Heparin natrium
Heparin sodium
Heparin sodium 1,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 1,000 units in dextrose 5% in plastic container
Heparin sodium 1,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 10,000 units in dextrose 5%
Heparin sodium 10,000 units in dextrose 5% in plastic container
Heparin sodium 10,000 units in sodium chloride 0.45%
Heparin sodium 10,000 units in sodium chloride 0.9%
Heparin sodium 12,500 units in dextrose 5%
Heparin sodium 12,500 units in dextrose 5% in plastic container
Heparin sodium 12,500 units in sodium chloride 0.45% in plastic container
Heparin sodium 12,500 units in sodium chloride 0.9%
Heparin sodium 2,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 2,000 units in dextrose 5% in plastic container
Heparin sodium 2,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 20,000 units and dextrose 5% in plastic container
Heparin sodium 20,000 units in dextrose 5% in plastic container
Heparin sodium 25,000 units and dextrose 5% in plastic container
 
Heparin sodium 25,000 units in dextrose 5%
Heparin sodium 25,000 units in dextrose 5% in plastic container
Heparin sodium 25,000 units in sodium chloride 0.45% in plastic container
Heparin sodium 25,000 units in sodium chloride 0.9%
Heparin sodium 25,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 5,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 5,000 units in dextrose 5% in plastic container
Heparin sodium 5,000 units in sodium chloride 0.45%
Heparin sodium 5,000 units in sodium chloride 0.9%
Heparin sodium 5,000 units in sodium chloride 0.9% in plastic container
Heparin sodium in plastic container
Heparin sodium preservative Free
Heparin sulfate
Heparin sulphate
Heparin, Low Molecular Weight
Heparin, Low-Molecular-Weight
Heparin, sodium salt
Heparina
Heparina [INN-Spanish]
Heparinate
Heparine
Heparine [INN-French]
Heparinic acid
Heparinsodiumsalt
Heparinum
Heparinum [INN-Latin]
Heparinum natricum
Hepathrom
Hepflush-10
Inno-Hep
Innohep
Isocinnamic acid
KB 101
Kabi 2165
LHN 1
LMWH
Lioton 1000
Lipo-hepin
Liquaemin
Liquaemin Lock Flush
Liquaemin Sodium
Liquaemin sodium preservative free
Liquemin
Logiparin
Lovenox
Lovenox HP
Low Molecular Weight Heparin
Low molecular weight heparin
Low molecular weight heparin sodium
Low-Molecular-Weight Heparin
Minolteparin sodium
MolPort-003-760-257
Multiparin
NSC174025
Nadroparin
Nadroparine
Novoheparin
OP 386
OP 622
Octaparin
PK 10,169
PK-10,169
PK-10169
PK10,169
PK10169
Pabyrin
Panheprin
Parnaparin
Parnaparin sodium
Parvoparin
Pularin
Reviparin
Reviparin sodium
Ro 11
Sandoparin
Sodium acid heparin
Sodium heparin
Sodium heparinate
Subeparin
Sublingula
Thromboliquine
Tinzaparin
Tinzaparin sodium
Triofiban
UNII-12M44VTJ7B
UNII-3S182ET3UA
UNII-E47C0NF7LV
UNII-T2410KM04A
UNII-ZZ45AB24CA
Unfractionated heparin
Vetren
Vitrum AB
WY 90493RD
alpha-Heparin
cis-.beta.-Carboxystyrene
cis-Cinnamic acid
enoxaparin
heparin
15
Dalteparinapproved3039041-08-1
Synonyms:
Daltepariininatrium
Dalteparin Sodyum
Dalteparin sodium
Dalteparin sodná sůl
Dalteparin-nátrium
Dalteparina sódica
 
Dalteparinnatrium
Dalteparino natrio druska
Dalteparinum Natricum
Dalteparyna sodowa
Daltéparine sodique
Heparin Fragment KABI 2165
Tedelparin
16Nadroparinapproved359041-08-1
17Vasodilator Agents3438
18Protective Agents7190
19Phosphodiesterase Inhibitors1254
20Antioxidants2928
21Platelet Aggregation Inhibitors2419
22Radiation-Protective Agents466
23Insulin, Globin Zinc4523
24insulin4524
25Antibodies6045
26Immunoglobulins6045
27Fibrinolytic Agents2317
28Heparin, Low-Molecular-Weight320
29Anticoagulants2516
30calcium heparin812
31Calcium, Dietary5525
32methionineNutraceutical80

Interventional clinical trials:

(show all 17)
idNameStatusNCT IDPhase
1SurVival of Lysosomal Acid Lipase Deficiency (LAL-D) Infants Treated With SebelipAse aLfaActive, not recruitingNCT01371825Phase 2, Phase 3
2Children With Lysosomal Acid Lipase Deficiency Who Previously Received Treatment With SBC-102TerminatedNCT01473875Phase 2, Phase 3
3Sitagliptin Versus Placebo in the Treatment of Non-alcoholic Fatty Liver DiseaseCompletedNCT01963845Phase 2
4Clinical Trial in Infants With Rapidly Progressive Lysosomal Acid Lipase DeficiencyActive, not recruitingNCT02193867Phase 2
5Measurement of Fibrinogen in Patients With Systemic Inflammatory Response Syndrome (SIRS), Sepsis or Chronicle Liver Disease on Intensive Care Units (ICU)Unknown statusNCT01169168
6The Efficacy of S-adenosyl Methionine (SAMe) Versus Pentoxiphylline in Patients With Non-alcoholic Steatohepatitis With FibrosisUnknown statusNCT02231333
7Non Alcoholic Fatty Liver Disease (NAFLD) in Hong KongUnknown statusNCT00577044
8Effect of Metformin on Disease Progression in Patients With Cryptogenic Cirrhosis (NASH-related Cirrhosis) With Diabetes or Impaired Glucose Tolerance or Insulin ResistanceCompletedNCT02234440
9Genetic Studies of Non-Alcoholic Fatty Liver DiseaseCompletedNCT01629095
10Bartonella in Liver Transplant PatientsRecruitingNCT02595710
11Assessement of the Prevalence of Lysosomal Acid Lipase Deficiency in Liver Post-transplant PatientsRecruitingNCT02851550
12Assessment of the Prevalence of Lysosomal Acid Lipase Deficiency in Patients Waiting for a Liver Transplant.RecruitingNCT02852304
13National Lysosomal Acid Lipase Deficiency StudyRecruitingNCT02372513
14Natural History of Noncirrhotic Portal HypertensionRecruitingNCT02417740
15Clinical Course of Interstitial Lung Diseases: European IPF Registry and BiobankRecruitingNCT02951416
16Be the Bridge Between Researchers and a Cure (GVHD, ALS, Hepatitis B, Alzheimer's Disease, Leukemia, and More)RecruitingNCT01931644
17Anticoagulation for Advanced Cirrhotic Patients After TIPSNot yet recruitingNCT03005444

Search NIH Clinical Center for Cirrhosis, Cryptogenic

Inferred drug relations via UMLS67/NDF-RT45:

Genetic Tests for Cirrhosis, Cryptogenic

About this section

Genetic tests related to Cirrhosis, Cryptogenic:

id Genetic test Affiliating Genes
1 Cirrhosis, Cryptogenic26
2 Cirrhosis, Noncryptogenic, Susceptibility to26

Anatomical Context for Cirrhosis, Cryptogenic

About this section

MalaCards organs/tissues related to Cirrhosis, Cryptogenic:

35
Liver, Lung

Animal Models for Cirrhosis, Cryptogenic or affiliated genes

About this section

Publications for Cirrhosis, Cryptogenic

About this section

Variations for Cirrhosis, Cryptogenic

About this section

UniProtKB/Swiss-Prot genetic disease variations for Cirrhosis, Cryptogenic:

69
id Symbol AA change Variation ID SNP ID
1KRT18p.His128LeuVAR_003852rs57758506
2KRT18p.Thr103AlaVAR_023054rs61136606
3KRT18p.Arg261GlnVAR_023056rs57354642
4KRT18p.Gly340ArgVAR_023057rs57370769
5KRT8p.Gly53ValVAR_023058rs61710484
6KRT8p.Tyr54CysVAR_023059
7KRT8p.Gly62CysVAR_023060rs11554495

Expression for genes affiliated with Cirrhosis, Cryptogenic

About this section
Search GEO for disease gene expression data for Cirrhosis, Cryptogenic.

Pathways for genes affiliated with Cirrhosis, Cryptogenic

About this section

Pathways related to Cirrhosis, Cryptogenic according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.1KRT18, KRT8
29.1KRT18, KRT8
3
Show member pathways
9.1KRT18, KRT8

GO Terms for genes affiliated with Cirrhosis, Cryptogenic

About this section

Cellular components related to Cirrhosis, Cryptogenic according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1keratin filamentGO:00450959.1KRT18, KRT8
2cell peripheryGO:00719449.1KRT18, KRT8
3intermediate filamentGO:00058828.8KRT18, KRT8

Biological processes related to Cirrhosis, Cryptogenic according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1extrinsic apoptotic signaling pathwayGO:00971919.6KRT18, KRT8
2tumor necrosis factor-mediated signaling pathwayGO:00332099.5KRT18, KRT8
3hepatocyte apoptotic processGO:00972849.1KRT18, KRT8
4viral processGO:00160328.8KRT18, KRT8

Molecular functions related to Cirrhosis, Cryptogenic according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1scaffold protein bindingGO:00971109.1KRT18, KRT8
2structural molecule activityGO:00051989.0KRT18, KRT8

Sources for Cirrhosis, Cryptogenic

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet